Expression of bcl-2 in testicular carcinoma: Correlation with tumor progression and MDR1/Pgp

Cancer

Volumn 83, Issue 2, 1998, Pages 331-336

  Eid, Hanna ^a   Gulyás, Miklos ^a   Géczi, Lajos ^b   Bodrogi, Istvan ^a   Institoris, Etel ^a   Bak, Mihály ^a  

^a NATIONAL INSTITUTE OF ONCOLOGY   (Hungary)

^b National Institute of Oncology ^*

Author keywords

Bcl 2 expression; Immunohistochemistry; Testicular carcinoma; Tumor progression

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER SCREENING; CANCER STAGING; CORRELATION FUNCTION; DIAGNOSTIC VALUE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; TESTIS CARCINOMA;

ADOLESCENT; ADULT; AGED; DISEASE PROGRESSION; GENE EXPRESSION; GENES, BCL-2; GERMINOMA; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PHENOTYPE; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-BCL-2; TESTICULAR NEOPLASMS;

EID: 0032527649     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19980715)83:2<331::AID-CNCR17>3.0.CO;2-U     Document Type: Article

References (28)

1. Yuniss JJ, Oken MM, Kaplan ME, Ensrud JCM, Howe RR, Theologides A. Distinctive chromosomal abnormalities in histologic subtypes of non-Hodgkin's lymphoma. N Engl J Med 1982;307:1231-6.
2. Tusjimoto Y, Finger LR, Yunis J, Nowell PC, Croce CM. Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation. Science 1984; 226:1097-9.
3. Ngan BY, Chen-Levy Z, Weiss LM, Warnke RA, Cleary ML. Expression in non-Hodgkin's lymphoma of the bcl-2 protein associated with the t(14;18) chromosomal translocation. N Engl J Med 1988;318:1638-44.
4. Pezzella F, Tse AGD, Cordell JL, Pulford KA, Gatter KC, Mason DY. Expression of the bcl-2 oncogene protein is not srecific for the 14; 18 chromosomal translocation. Am J Pathol 1990;137:225-32.
5. Zutter M, Hockenbery D, Silverman GA, Korsmeyer SJ. Immunolocalization of the bcl-2 protein within hematopoietic neoplasms. Blood 1991;78:1062-8.
6. Alnemri ES, Fernendes TF, Haldar S, Crocec M, Litwack G. Involvement of bcl-2 in glucocorticoid-induced apoptosis of human pre-B-leukemias. Cancer Res 1992;52:491-5.
7. Deng G, Podack ER. Suppression of apoptosis in a cytotoxic T-cell line by interleukin 2-mediated gene transcription and deregulated expression of the protooncogene bcl-2. Proc Natl Acad Sci U S A 1993;90:2189-93.
8. Zhong LT, Sarafian T, Kane DJ, Charles AC, Mah SP, Edwards RH, et al. bcl-2 inhibits death of central neural cells induced by multiple agents. Proc Natl Acad Sci U S A 1993; 90:4533-7.
9. McDonnell TJ, Deane N, Platt FM, Nunes G, Jaeger U, McKearn JP, et al. bcl-2-immunoglobulin transgenic mice demonstrate extended B-cell survival and follicular lymphoproliferation. Cell 1989;57:79-88.
10. McDonnell TJ, Korsmeyer SJ. Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14;18). Nature 1991;349:254-6.
11. Nunez G, London L, Hockenbery D, Alexander M, McKearn JP, Korsmeyer SJ. Deregulated bcl-2 gene expression selectively prolongs survival of growth factor - deprived hemopoietic cell lines. J Immunol 1990;144:3602-10.
12. Yuniss JJ, Mayer MG, Arnesen MA, Aeppli DP, Oken MM, Frizzera G. bcl-2 and other genomic alterations in the prognosis of large-cell lymphoma. N Engl J Med 1989;320:1047-54.
13. Campos L, Rouault JP, Sabido O, Oriol P, Roubi N, Vasselon C, et al. High expression of bcl-2 protein in acute myeloid leukemia cells is associated with poor response to chemotherapy. Blood 1993;18:3091-6.
14. Castle VP, Heidelberger KP, Bromberg J, Ou XL, Dole M, Nunez G. Expression of the apoptosis-suppressing protein bcl-2 in neuroblastoma is associated with unfavorable histology and N-myc amplification. Am J Pathol 1993;143:1543-50.
15. McDonnell TJ, Troncoso P, Brisbay SM, Logothetis C, Chung LWK, Hsieh J, et al. Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer. Cancer Res 1992; 52:6940-4.
16. Furunya Y, Krajewski S, Epstein JI, Reed JC, Isaacs JT. Expression of bcl-2 and the progression of human and rodent prostatic cancers. Clin Cancer Res 1996;2:389-98.
17. Joensuu H, Pylkkanen L, Toikkanen S. bcl-2 protein expression and long-term survival in breast cancer. Am J Pathol 1994;145:1191-8.
18. Doglioni C, Deitos AP, Laurino L, Barbareschi M, Chiarelli C, Viale G. bcl-2 expression in breast carcinoma. Mod Pathol 1994;7:15A.
19. Pezzella F, Turley H, Kuzu I, Tungekar MF, Dunnill MS, Pierce CB, et al. bcl-2 protein in non-small-cell lung carcinoma. N Engl J Med 1993;329:690-4.
20. International Union Against Cancer. TNM classification of malignant tumours. 4th edition. New York: Springer-Verlag, 1987.
21. Javadpour N. The role of biologic tumor markers in testicular cancer. Cancer 1980;45(Suppl):1755-61.
22. Mostofi FK, Sesterhenn IA, Davis CJ. World Health Organization international histological classification of germ-cell tumours of the testes. In: Jones WG, Ward AM, Anderson CK, editors. Germ-cell tumours. 2nd edition. Oxford: Pergamon, 1986:1-23.
23. Cattoretti G, Becker GM, Key G, Duchrow M, Schlüter C, Gall J, et al. Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIBI and MIB3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol 1992;168:357-63.
24. Zhao M, Zhang NX, Economou M, Blaha I, Laissue JA, Zimmermann A. Immunohistochemical detection of bcl-2 protein in liver lesions: bcl-2 protein is expressed in hepatocellular carcinomas but not in liver cell dysplasia. Histopathology 1994;25:237-45.
25. Eid H, Bodrogi I, Csókay B, Oláh E, Bak M. Multidrug resistance of testis cancers: the study of clinical relevance of P-glycoprotein expression. Anticancer Res 1996;6:3447-52.
26. Weinstein RS, Jakate SM, Dominguez JM, Lebovitz MD, Koukoulis GK, Klusense LF, et al. Relationship of the expression of the multidrug resistance gene product (P-glycoprotein) in human colon carcinoma to local tumor aggressiveness and lymph node metastasis. Cancer Res 1991;51: 2720-6.
27. Bradley G, Sharma R, Rajalakshmi S, Ling V. P-glycoprotein expression during tumor progression in the rat liver. Cancer Res 1992;52:5154-61.
28. Pinedo HM, Giaccone G. P-glycoprotein: a marker of cancer-cell behavior. N Engl J Med 1995;333:1417-9.